ArticleClinical and experimental nephrology2026
Synergistic negative effect of selenium deficiency and thyroid dysfunction on cardiovascular disease in hemodialysis patients.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSelenium is an essential trace element, and its deficiency is associated with thyroid dysfunction, which is known as a cardiovascular risk factor. Hemodialysis (HD) patients are particularly prone to selenium deficiency, and this nutritional factor may increase the risk of thyroid dysfunction and subsequently cardiovascular disease (CVD). Therefore, we investigated selenium deficiency in HD patients and tried to analyze the effect of selenium deficiency on thyroid dysfunction and its correlation with CVD.
methodsA cross-sectional study was conducted with 183 chronic HD patients. Selenium deficiency was defined as a serum selenium level below 90 µg/L. Patients were categorized into subgroups based on selenium status and/or thyroid hormone dysfunction. CVD prevalence was assessed.
resultsOf the 183 subjects, 79 (43.2%) had selenium deficiency, which was associated with a trend toward higher thyroid dysfunction and increased CVD. In the subgroup analysis, the group with both selenium deficiency and thyroid dysfunction showed a significantly higher CVD prevalence of 68.1% compared to other groups. Additionally, in the logistic regression analysis for CVD risk factors, selenium deficiency/thyroid dysfunction was found to have a significant odds ratio of 3.171.
conclusionsThis study demonstrates that selenium deficiency is associated with thyroid dysfunction and an increased CVD risk in chronic HD patients. Moreover, a negative synergistic effect on CVD was observed when both selenium deficiency and thyroid dysfunction were present.
Indexed as
Identifiers
41091352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.